全文获取类型
收费全文 | 2794篇 |
免费 | 245篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 102篇 |
妇产科学 | 42篇 |
基础医学 | 300篇 |
口腔科学 | 77篇 |
临床医学 | 263篇 |
内科学 | 544篇 |
皮肤病学 | 38篇 |
神经病学 | 268篇 |
特种医学 | 276篇 |
外科学 | 267篇 |
综合类 | 86篇 |
一般理论 | 3篇 |
预防医学 | 330篇 |
眼科学 | 26篇 |
药学 | 163篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 249篇 |
出版年
2021年 | 24篇 |
2020年 | 17篇 |
2019年 | 27篇 |
2018年 | 30篇 |
2017年 | 33篇 |
2016年 | 32篇 |
2015年 | 42篇 |
2014年 | 76篇 |
2013年 | 80篇 |
2012年 | 127篇 |
2011年 | 130篇 |
2010年 | 86篇 |
2009年 | 73篇 |
2008年 | 119篇 |
2007年 | 144篇 |
2006年 | 117篇 |
2005年 | 98篇 |
2004年 | 95篇 |
2003年 | 71篇 |
2002年 | 103篇 |
2001年 | 83篇 |
2000年 | 83篇 |
1999年 | 92篇 |
1998年 | 53篇 |
1997年 | 46篇 |
1996年 | 53篇 |
1995年 | 57篇 |
1994年 | 37篇 |
1993年 | 53篇 |
1992年 | 60篇 |
1991年 | 44篇 |
1990年 | 67篇 |
1989年 | 65篇 |
1988年 | 61篇 |
1987年 | 69篇 |
1986年 | 59篇 |
1985年 | 60篇 |
1984年 | 38篇 |
1983年 | 36篇 |
1982年 | 30篇 |
1981年 | 27篇 |
1980年 | 35篇 |
1979年 | 28篇 |
1978年 | 31篇 |
1977年 | 28篇 |
1976年 | 20篇 |
1975年 | 17篇 |
1974年 | 26篇 |
1973年 | 16篇 |
1969年 | 15篇 |
排序方式: 共有3052条查询结果,搜索用时 0 毫秒
11.
Ikuhiro Kida Douglas L Rothman Fahmeed Hyder 《Journal of cerebral blood flow and metabolism》2007,27(4):690-696
Changes in cerebral blood flow (CBF), volume (CBV), and oxygenation (blood-oxygenation level dependent (BOLD)) during functional activation are important for calculating changes in cerebral metabolic rate of oxygen consumption (CMRo2) from calibrated functional MRI (fMRI). An important part of this process is the CBF/CBV relationship, which is signified by a power-law parameter: gamma=ln (1+DeltaCBV/CBV)/ln (1+DeltaCBF/CBF). Because of difficulty in measuring CBF and CBV with MRI, the value of gamma is therefore assumed to be approximately 0.4 from a prior primate study under hypercapnia. For dynamic fMRI calibration, it is important to know if the value of gamma varies after stimulation onset. We measured transient relationships between DeltaCBF, DeltaCBV, and DeltaBOLD by multimodal MRI with temporal resolution of 500 ms (at 7.0 T) from the rat somatosensory cortex during forepaw stimulation, where the stimulus duration ranged from 4 to 32 secs. Changes in CBF and BOLD were measured before the administration of the contrast agent for CBV measurements in the same subjects. We observed that the relationship between DeltaCBF and DeltaCBV varied dynamically from stimulation onset for all stimulus durations. Typically after stimulation onset and at the peak or plateau of the DeltaCBF, the value of gamma ranged between 0.1 and 0.2. However, after stimulation offset, the value of gamma increased to 0.4 primarily because of rapid and slow decays in DeltaCBF and DeltaCBV, respectively. These results suggest caution in using dynamic measurements of DeltaCBF and DeltaBOLD required for calculating DeltaCMRo2 for functional stimulation, when either DeltaCBV has not been accurately measured or a fixed value of gamma during hypercapnia perturbation is used. 相似文献
12.
Laura I Sacolick Douglas L Rothman Robin A de Graaf 《Magnetic resonance in medicine》2007,57(3):548-553
Because of their excellent slice profiles and high immunity to RF inhomogeneity, adiabatic full passage (AFP) pulses are ideal for use in spatial localization. The nonlinear, position-dependent phase of a single AFP pulse generated during refocusing of transverse magnetization traditionally is eliminated by using identical pairs of AFP pulses, at the expense of increased RF power deposition and increased echo time (TE). Here it is shown that one can achieve significant phase refocusing by executing single AFP pulses along non-equivalent spatial axes. When used for volume selection in MR spectroscopic imaging (MRSI) the remaining nonlinear phase becomes inconsequential when the phase across a spectroscopic volume is small. Selection of rectangular and octagonal volumes is demonstrated with half the number of AFP pulses used in the traditional approach. It is shown that octagonal volume selection in the human brain provides excellent suppression of extracranial lipids, and thus allows multislice (1)H MRSI at 4 Tesla to be performed within the guidelines for RF power deposition. 相似文献
13.
14.
15.
The purpose of this study was to evaluate the ability of MRI to identify a primary site of malignancy in the breast of patients who present clinically with ipsilateral lymph nodes containing metastatic carcinoma but whose physical and mammographic examination are negative. MRI of the breast was performed on four patients using a variety of imaging parameters, all with and without gadolinium contrast. All patients had biopsy-proven adenocarcinoma of the ipsilateral axilla, with negative physical and mammographic examinations. Foci of enhancement assessed visually on precontrast and postcontrast scans (n = 1) and on substraction studies (n = 3) were considered suspicious under the clinical circumstances defined for this study. Lesions identified on MRI were re-identified on ultrasound examination and either preoperative localization for excisional biopsy or tissue sampling was performed. Surgery was performed and histopathologic correlation was obtained in all cases. Primary sites of breast carcinoma were identified in all four patients, with multiple sites of malignancy identified in three of four patients. Breast conservation therapy was made possible for three of four patients based on the results of the MRI study showing sites of malignancy and no features of cancer elsewhere in the breast. Follow-up data of 1, 2, and 5 years of these patients show no evidence of recurrent disease. MRI of the breast is a useful technique for identifying primary sites of malignancy in patients presenting with ipsilateral lymph nodes positive for metastatic adenocarcinoma when the physical and mammographic examinations are negative. 相似文献
16.
Daniel L. Rubin Karen L. Falk Malcolm J. Sperling Michael Ross Sanjay Saini Barry Rothman Frank Shellock Elias Zerhouni David Stark Eric K. Outwater Udo Schmiedl Louis C. Kirby Judith Chezmar Terry Coates Miles Chang Jeffery M. Silverman Neil Rofsky Keith Burnett Julie Engel Stuart W. Young 《Journal of magnetic resonance imaging : JMRI》1997,7(5):865-872
The purpose of this study was to assess the effectiveness and safety of Gadolite Oral Suspension as a gastrointestinal (GI) contrast agent for MRI in a phase II and two phase III multicenter clinical trials. Gadolite was administered to 306 patients with known or suspected abdominal and/or pelvic disease. MRI with T1- and T2-weighted sequences was performed before and after ingestion. Efficacy was evaluated by having two masked readers rate the certainty of their MR diagnosis (0 = uncertain, 1 = probable, 2 = definite) on randomly presented pre- and post-Gadolite Oral Suspension enhanced images. Principal investigators also evaluated the images and established the final diagnosis. Vital signs, clinical chemistries, and adverse events were documented. Blood and urine samples were analyzed for gadolinium content to determine whether Gadolite Oral Suspension was absorbed systemically. Certainty in MR diagnosis increased significantly (P < .001) for both blinded readers between pre- and post-Gadolite images (.49–1.18 for reader 1; .46–1.53 for reader 2). Sensitivity, specificity, and accuracy also increased for both masked readers. No gadolinium was detected in blood or urine samples. There were no serious adverse events and no apparent drug-related trends in mean vital signs or laboratory values. Gadolite is a highly effective, safe, and well tolerated contrast agent for clinical use with MRI. 相似文献
17.
Intestinal obstruction proximal to a transition zone without an interposed physical barrier usually indicates Hirschsprung disease. The authors report one case of focal small bowel muscular thinning just distal to a transition zone that produced clinical and radiographic findings that simulated long-segment Hirschsprung disease in a 2-day-old infant. 相似文献
18.
19.
R B Rothman V Bykov A Reid B R De Costa A H Newman A E Jacobson K C Rice 《Neuropeptides》1988,12(3):181-187
Norbinaltorphimine (nor-BNI) is a bifunctional reagent developed as a selective antagonist of the kappa opioid receptor. In this paper we examined the in vitro selectivity of nor-BNI, 6-desoxy-6 beta-fluoronaltrexone (cycloFOXY), and the enantiomer of cycloFOXY, among opioid receptor subtypes. Nor BNI exhibited the highest affinity for kappa binding sites labeled by 3H-U69593 (Ki = 1.8nM), and was 27- to 29-fold less potent at mu and delta binding sites. In contrast, cycloFOXY had the highest affinity for mu binding sites (Ki = 2.62 nM), and bound to kappa and delta binding sites with Ki's of 9.3 nM and 89 nM, respectively. The enantiomer of cycloFOXY, did not inhibit binding even at concentrations greater than 10 microM, validating in part the use of 18F-labeled (+)-cycloFOXY to estimate "non-specific binding" in positron emission tomography. Additionally, we report that (S,S)-U50 488 and (R.R)-U50 488 bind to kappa binding sites labeled by 3H-U69 593 with Ki's of 0.89 nM and 299 nM, respectively. 相似文献
20.
Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy 总被引:3,自引:0,他引:3
Kelsell RE; Gregory-Evans K; Payne AM; Perrault I; Kaplan J; Yang RB; Garbers DL; Bird AC; Moore AT; Hunt DM 《Human molecular genetics》1998,7(7):1179-1184
The dominant cone-rod dystrophy gene CORD6 has previously been mapped to
within an 8 cM interval on chromosome 17p12-p13. The retinal- specific
guanylate cyclase gene (RETGC-1), which maps to within this genetic
interval and previously was implicated in Leber's congenital amaurosis, was
screened for mutations within this family and in a panel of small families
and individuals with various cone and cone- rod dystrophy phenotypes. A
missense mutation (E837D) was identified in affected members of the CORD6
family, as well as a second missense mutation (R838C) in three other
families with dominant cone-rod dystrophy. RETGC-1 is only the fourth gene
to be implicated in cone-rod dystrophy and this is the first report of
dominant mutations in this gene.
相似文献